Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) | MicrobiomeTrials← Back to trialsNCT05797246
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-08-02Est. Completion: 2027-07-31
Enrollment target: 21 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oropharyngeal Squamous Cell CarcinomaStage II Laryngeal Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This phase II trial tests the addition of chemotherapy, with carboplatin and paclitaxel, or chemo-immunotherapy, with ca…
Tucson, United StatesEst. completion Feb 1, 2033
Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus InfectionLaryngeal DiseasesTracheal DiseasesRespiratory Tract Neoplasm
Background:
Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths called papilloma…
Bethesda, United StatesEst. completion Jul 1, 2029
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
This phase II trial tests how well biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy …
Duarte, United StatesCompleted Mar 9, 2027